Company Executives

Management Team

From the proxy statement filed Oct 15, 2025

Officer	Age	In this role	Joined	Pay	Source
David Weinstein Also a director Chief Executive Officer and Director	65	Not stated	Not stated	Not reported
Nathen Fuentes Chief Financial Officer	42	Since 2025 1 year	Not stated	Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Oct 15, 2025

Directors

serving now

Independent

3 of 3

stated in the proxy; 1 not stated

Average tenure

1.0 years

from year joined

CEO also chairs the board

Not stated

no chair stated

Director	Age	On board	Independent	Committees	Other public boards	Pay
David Weinstein CEO	65	2024 1 year	Not stated	None stated	None stated	Paid as CEO
James A. McNulty	75	Not stated	Independent	Audit Committee · Chair Compensation Committee · Chair Nominating and Corporate Governance Committee	None stated	Not stated
Douglas W. Calder	58	Not stated	Independent	Audit Committee Compensation Committee Nominating and Corporate Governance Committee · Chair	Zevra Therapeutics, Inc.	Not stated
Mark A. Collins	63	Not stated	Independent	Audit Committee Compensation Committee Nominating and Corporate Governance Committee	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Oct 15, 2025 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

Management Team

Board of Directors

Related-party transactions

No related-party transactions disclosed